Loading…
Aptorum Group Limited is projected to decline to $0.7655 by 2027, a -2% move from its current price of $0.782. APM is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $0.7493 | $0.7815 | $0.815 | -0.07% |
| Jul 15 | $0.7359 | $0.781 | $0.8288 | -0.13% |
| Jul 16 | $0.7256 | $0.7804 | $0.8394 | -0.20% |
| Jul 17 | $0.717 | $0.7799 | $0.8483 | -0.27% |
| Jul 18 | $0.7095 | $0.7794 | $0.8562 | -0.33% |
| Jul 19 | $0.7027 | $0.7789 | $0.8634 | -0.40% |
| Jul 20 | $0.6964 | $0.7784 | $0.8699 | -0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6964 | $0.7784 | $0.8699 | -0.46% |
| Week 2 | $0.662 | $0.7748 | $0.9067 | -0.93% |
| Week 3 | $0.636 | $0.7712 | $0.935 | -1.39% |
| Week 4 | $0.6145 | $0.7676 | $0.9588 | -1.85% |
| Week 5 | $0.5958 | $0.764 | $0.9797 | -2.30% |
| Week 6 | $0.5791 | $0.7605 | $0.9986 | -2.76% |
| Week 7 | $0.564 | $0.7569 | $1.02 | -3.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aptorum Group Limited, through its subsidiaries, is a clinical stage biopharmaceutical company focused on discovering, developing, and commercializing therapeutic products to treat oncology and infectious diseases. Its pipeline includes SACT-1, a repurposed drug candidate in phase 1 clinical trial to treat neuroblastoma and other cancer types, and ALS-4, a repurposed small molecule in phase 1 to treat bacterial infections such as Staphylococcus aureus, Mycobacterium tuberculosis, and Pseudomonas aeruginosa. The company also develops SACT-COV19, a repurposed small molecule in preclinical trial for coronavirus disease, along with SACT-2 and SACT-3, and ALS-1 in preclinical trials to treat bacterial infections caused by Staphylococcus aureus including MRSA, and ALS-2/3 in preclinical trials for gram-positive bacterial infections.
The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Aptorum Group Limited (APM) is a healthcare company currently trading with a price of $0.7732 and a market capitalization of $6.3M, ranking 4968. Its current price and market position place it among smaller-cap biotechnology peers. The asset’s forecasted price trajectory shows an average price of $0.7732 in 2026, rising to $2.97 on the 2050 horizon, with varying yearly averages along the way.
The forecast signal evolves from NEUTRAL in the near term to BULLISH in the longer term, indicating potential upside in the multi-year path.
A major floor 35.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.5% away) — a key level to hold.
The nearest ceiling, 49.6% above — a clean break opens room to run.
A major ceiling 67.2% above — clearing it would confirm fresh momentum.
Key APM support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of APM market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7838 | Sell | $0.7844 | Sell |
| MA 10 | $0.785 | Sell | $0.7939 | Sell |
| MA 20 | $0.8144 | Sell | $0.8215 | Sell |
| MA 50 | $0.8695 | Sell | $0.8606 | Sell |
| MA 100 | $0.8714 | Sell | $0.9131 | Sell |
| MA 200 | $1.10 | Sell | $1.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.87 | Neutral |
| Stoch RSI (14) | 36.40 | Neutral |
| CCI (20) | -64.90 | Neutral |
| Williams %R (14) | -86.36 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -5.56 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 13.64 | Buy |
| TRIX (15) | -0.54 | Sell |
| Awesome (5,34) | -0.10 | Sell |
| Ultimate (7,14,28) | 44.62 | Neutral |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.78 | Buy |
| ADX (14) | 15.60 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is BEARISH, with RSI14 at 40. The price is below the SMA50 of $0.8868 and the SMA200 of $1.14. These indicators suggest caution in the near term as momentum remains limited. The stock’s near-term price action faces a resistance at $1.17 and a support at $0.773, framing a cautious outlook.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.74 | $0.782 | $0.93 | 0% | Neutral | |
| $0.579 | $0.7655 | $1.09 | -2% | Neutral | |
| $0.5549 | $0.7679 | $1.15 | -2% | Neutral | |
| $0.6829 | $0.9821 | $1.53 | +26% | Bullish | |
| $0.7538 | $1.12 | $1.81 | +43% | Bullish | |
| $0.6567 | $1.01 | $1.68 | +29% | Bullish | |
| $0.6186 | $0.9795 | $1.67 | +25% | Bullish | |
| $0.5973 | $0.9731 | $1.70 | +24% | Bullish | |
| $0.5968 | $0.9993 | $1.78 | +28% | Bullish | |
| $0.6922 | $1.19 | $2.17 | +52% | Bullish | |
| $0.7037 | $1.37 | $2.71 | +75% | Bullish | |
| $1.35 | $3.00 | $6.66 | +284% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.74 | $0.782 | $0.9283 | +0.00% |
| August 2026 | $0.605 | $0.7245 | $0.8982 | -7.36% |
| September 2026 | $0.6079 | $0.736 | $0.9278 | +1.59% |
| October 2026 | $0.629 | $0.7688 | $0.9829 | +4.46% |
| November 2026 | $0.6032 | $0.7432 | $0.9613 | -3.33% |
| December 2026 | $0.573 | $0.7114 | $0.93 | -4.28% |
Click any year to see its month-by-month APM forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect APM to range from $0.74 to $0.93 through 2026. The $0.782 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The APM price prediction for 2027 points to an average of $0.7655 (low $0.579, high $1.09) — a potential decline of -2% on today's $0.782. Price action looks broadly range-bound.
In 2028, APM is projected to trade between $0.5549 and $1.15, averaging $0.7679 — a potential decline of -2% from today's $0.782. That is up 0% on the projected 2027 average. A consolidation phase looks the most probable path here.
Aptorum Group Limited's 2029 outlook centres on $0.9821, within a $0.6829 to $1.53 range. That is up +28% on the projected 2028 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2030, APM could reach as high as $1.81, with a base case around $1.12 and support toward $0.7538 — roughly +43% from $0.782. Buyers look set to stay in control over this stretch.
Expect APM to range from $0.6567 to $1.68 through 2031. The $1.01 average target implies a +29% move from current prices. That is -10% versus the projected 2030 average. Momentum favours further upside here.
The APM price prediction for 2032 points to an average of $0.9795 (low $0.6186, high $1.67) — a potential gain of +25% on today's $0.782. Buyers look set to stay in control over this stretch.
In 2033, APM is projected to trade between $0.5973 and $1.70, averaging $0.9731 — a potential gain of +24% from today's $0.782. That is -1% versus the projected 2032 average. Momentum favours further upside here.
Aptorum Group Limited's 2034 outlook centres on $0.9993, within a $0.5968 to $1.78 range. That is up +3% on the projected 2033 average. That marks a +28% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, APM could reach as high as $2.17, with a base case around $1.19 and support toward $0.6922 — roughly +52% from $0.782. Momentum favours further upside here.
Expect APM to range from $0.7037 to $2.71 through 2040. The $1.37 average target implies a +75% move from current prices. That is up +15% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The APM price prediction for 2050 points to an average of $3.00 (low $1.35, high $6.66) — a potential gain of +284% on today's $0.782. Momentum favours further upside here.
Investing $1,000 in APM today (≈ 1,278.772379 APM) could be worth
$3,836.41
+$2,836.41 (+284%) by 2050 · US Dollar
Based on the average projected APM price of $3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in APMwould be worth at today's price.
$1,000 invested in APM on Jul 10, 2025 (≈ 1,075.268809 APM) would be worth
$840.86
-$159.14 (-15.9%) today · 0.84× · US Dollar
Based on a APM entry price of $0.93 vs. today's $0.782.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.802 | $975.06 | -2.5% |
| 1 month ago | $0.904 | $865.04 | -13.5% |
| 3 months ago | $0.91 | $859.34 | -14.1% |
| 6 months ago | $1.04 | $751.92 | -24.8% |
| 1 year ago | $0.93 | $840.86 | -15.9% |
| All time (5.0y) ago | $28.6 | $27.34 | -97.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our APM forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $10.15M
The multi-year forecast shows a shift from neutral to bullish over time. In 2026 the avg price is $0.7732 with a neutral sentiment, and in 2029 the avg price rises to $0.9902 with a bullish stance (ROI 28.1%). The forecast continues higher into 2030 with an avg of $1.15 and ROI 48.6% (bullish), and remains bullish through 2031–2033 with avg values around $0.9527–$0.9416 and ROIs ranging from ~23% to ~22%.
By 2035 the avg is $1.15 with ROI 49.1% (bullish), and by 2040 the avg reaches $1.23 with ROI 59.7% (bullish). The strongest upside appears in 2050, with an avg of $2.97, a max of $6.82, and ROI of 283.5% (bullish). These figures illustrate a path of meaningful appreciation in the later years, counterbalanced by near-term volatility and some years of muted or negative returns (e.g., 2027 ROI -4.4%, 2028 ROI -8.4%).
Note: these are conditional estimates, not guarantees.
Tap a question to reveal the answer.
Avg $1.15 with ROI 48.6% and bullish sentiment. These are estimates, not guarantees.
Yes, the forecast lists a max of $6.82 in 2050 with an avg of $2.97 and ROI 283.5%, bullish. These are estimates, not guarantees.
Current price $0.7732; market cap $6.3M. These are estimates, not guarantees.
Avg $0.7732; min $0.74, max $0.9248; ROI 0; sentiment NEUTRAL. These are estimates, not guarantees.
The forecast shows mixed timing, with neutral in the near term (2026–2028) and bullish upside later (e.g., 2029 onward), including 2030 avg $1.15 and ROI 48.6% and 2050 avg $2.97 with ROI 283.5%. These are estimates, not guarantees.
Aptorum Group Limited Community Discussion
0Share your Aptorum Group Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.